Stock CRSP CRISPR THERAPEUTICS AG
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart CRISPR Therapeutics AG

Equities

CRSP

CH0334081137

Real-time Estimate Cboe BZX
Other stock markets
 02:13:43 2024-05-03 pm EDT 		5-day change 1st Jan Change
56.09 USD +1.85% Intraday chart for CRISPR Therapeutics AG +4.03% -10.42%
Apr. 18 Citigroup Adjusts CRISPR Therapeutics' Price Target to $89 From $88, Keeps Buy Rating MT
Apr. 17 Crispr Therapeutics Insider Sold Shares Worth $1,173,232, According to a Recent SEC Filing MT

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
CRISPR THERAPEUTICS AG
Other Biotechnology & Medical Research
+1.82%+4.03%-10.42%+14.01%+38.23% 4.67B
Bearish
Neutral
Neutral
  1. Stock Market
  2. Equities
  3. CRSP Stock
  4. Charts CRISPR Therapeutics AG
  5. Relative Strength Chart